Received Dec 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
caught COVID; caught COVID; This is a spontaneous report received from a Consumer or other non HCP. Other Case identifier(s): US-MO-MOC20251120000002 (Moderna Therapeutics), MOD-2025-791587 (Moderna Therapeutics). A patient (age and gender not provided) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), on 19May2025 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Varicella zoster vaccine (DOSE NUMBER UNKNOWN; MANUFACTURER UNKNOWN), for Immunization; Tdap (DOSE NUMBER UNKNOWN; MANUFACTURER UNKNOWN), for Immunization; Rsv vaccine (DOSE NUMBER UNKNOWN; MANUFACTURER UNKNOWN), for Immunization; Fluzone (DOSE NUMBER UNKNOWN), for Immunization; Spikevax 2024-2025 (DOSE 7 (BOOSTER); intramuscular), administration date: Sep2024, for COVID-19 immunization; Pfizer biontech covid-19 vaccine (DOSE 6 (BOOSTER)), administration date: Oct2023, for Covid-19 immunization; Pfizer biontech covid-19 vaccine (DOSE 5 (BOOSTER)), administration date: Sep2023, for Covid-19 immunization; Spikevax (DOSE 4 (BOOSTER)), administration date: Jun2022, for Covid-19 immunization; Spikevax (DOSE 3 (BOOSTER)), for Covid-19 immunization; Spikevax nos (DOSE 2), for Covid-19 immunization; Spikevax nos (DOSE 1), for Covid-19 immunization. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 22Aug2025, outcome "unknown" and all described as "caught COVID". Therapeutic measures were taken as a result of vaccination failure, covid-19. The patient was given nirmatrelvir, ritonavir (PAXLOVID) as treatment of COVID-19. Batch/lot number is not provided, and it cannot be obtained.